Blog
FDA asks Sarepta to stop shipping gene therapy after patient deaths. Sarepta says no.
The FDA says it has asked Sarepta Therapeutics to voluntarily stop all shipments of Elevidys after the company confirmed a third patient death related to one of its gene therapies.